Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,613,619
+$1,033,242 QoQ
Shares Held
30,256
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#1,061
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2020CallValue
$24,108,750
CallShares
225,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. ABBV ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
96,626 | $20,877,013 | |
| 2 | AZN |
Astrazeneca PLC
|
62,530 | $11,856,938 | |
| 3 | SNY |
Sanofi
|
269,515 | $11,497,509 | |
| 4 | LLY |
ELI LILLY & Co
|
8,040 | $9,643,418 | |
| 5 | NVS |
Novartis AG
|
50,000 | $7,836,000 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
30,256 | $7,613,619 | |
| 7 | MRK |
Merck & Co., Inc.
|
58,600 | $7,530,100 | |
| 8 | JNJ |
Johnson & Johnson
|
28,831 | $7,322,209 |
All Filings in ABBV
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,613,619 | 30,256 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,580,377 | 30,256 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,770,743 | 25,256 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,847,774 | 25,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,688,018 | 25,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,339,237 | 30,256 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,087,291 | 34,256 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,504,240 | 38,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,517,760 | 38,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,919,800 | 38,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,128,620 | 46,000 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $6,856,760 | 46,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,544,880 | 56,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,040,310 | 63,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,696,600 | 60,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $21,780,269 | 162,285 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,447,846 | 218,385 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $30,962,037 | 190,994 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $62,851,867 | 464,194 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $64,322,233 | 596,294 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,248,092 | 366,194 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $64,877,890 | 599,500 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,108,750 | 225,000 | Call | Defined | 2021-02-16 | |
| 2020-12-31 | $36,431,000 | 340,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,948,750 | 125,000 | Call | Defined | 2020-11-12 | |
| 2020-09-30 | $69,196,100 | 790,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $72,122,831 | 734,598 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $12,571,350 | 165,000 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||